Abstract
To the Editor. —In the May 1986 issue of theArchives, Dr Fine 1 wrote an editorial supporting the Collaborative Ocular Melanoma Study (COMS). As a physician and a taxpayer, I would like to express my opposition to the COMS. As a physician, I cannot support the study design because of the following reasons: The credibility of the COMS is somewhat weakened by the fact that several of the outstanding leaders in the field (such as Drs Augsburger, Char, Coleman, Ellsworth, Gragoudas, Seddon, and Shields) are not participating because of problems in the protocol. The study has a shaky scientific basis. Dr Fine, while professing not to know whether to take the eye out or leave it in, asserts that he knows what to do with small melanomas. The COMS has excluded melanomas less than 3 mm in height from randomization. What is so magical about 3 mm?
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
